- Tytuł:
- 64O Lenvatinib plus pembrolizumab, pemetrexed, and a platinum (len + pembro + chemo) as first-line therapy for metastatic non squamous non-small cell lung cancer (NSCLC): Phase III LEAP-006 study
- Autorzy:
- Źródło:
- In Immuno-Oncology and Technology December 2023 20 Supplement
Czasopismo naukowe